Effect of Endotracheal Tube Plus STYLET Versus Endotracheal Tube Alone (STYLETO)

September 26, 2025 updated by: University Hospital, Montpellier

Effect of Endotracheal Tube Plus STYLET Versus Endotracheal Tube Alone on Successful First-Pass Orotracheal Intubation Among Critically Ill Patients: the Randomised STYLETO Study Protocol"

Patients admitted to Intensive Care Units (ICU) often require respiratory support. Orotracheal intubation is one of the most frequent procedures performed in ICU.When performed in emergency settings, intubation is a challenging issue as it may be associated with life-threatening complications in up to one third of cases

Using a preshaped endotracheal tube plus stylet may have potential advantages over endotracheal tube alone without stylet. The stylet is a rigid but malleable introducer which fits inside the endotracheal tube and allows for manipulation of the tube shape; usually into a hockey stick shape, to facilitate passage of the tube through the laryngeal inlet. The stylet can help to increase success of intubation in operating rooms

Study Overview

Detailed Description

Patients admitted to Intensive Care Units (ICU) often require respiratory support. Orotracheal intubation is one of the most frequent procedures performed in ICU. When performed in emergency settings, intubation is a challenging issue as it may be associated with life-threatening complications in up to one third of cases.Severe hypoxaemia occurring during intubation procedure can result in cardiac arrest,cerebral anoxia, and death.Difficult intubation is known to be associated with life-threatening complications both in operating room and in emergent conditions.ICU intubation conditions are worse than intubation conditions in operative rooms.A non-planned and urgent intubation procedure, severity of patient disease and ergonomic issues explain the morbidity associated with intubation in ICU.To prevent and limit the incidence of severe hypoxemia following intubation and its complications, several intubation algorithms have been developed ,and specific risk factors for difficult intubation in ICU have been identified.

In 2018, a large multicenter study reported first-attempt intubation success rates using direct laryngoscopy of 70% and videolaryngoscopy of 67%. In 2019, a multicentre randomized trial,assessing whether positive-pressure ventilation with a bag-mask device (bag-mask ventilation) during tracheal intubation of critically ill adults prevents hypoxemia, reported a first-attempt success rate of 81%. Other authors reported an overall first-attempt intubation success rate of 74%. The 20% to 40% first-attempt failure rates throughout studies highlight the opportunity to improve the safety and efficiency of this critical procedure. Using a preshaped endotracheal tube plus stylet may have potential advantages over endotracheal tube alone without stylet. The stylet is a rigid but malleable introducer which fits inside the endotracheal tube and allows for manipulation of the tube shape; usually into a hockey stick shape, to facilitate passage of the tube through the laryngeal inlet. The stylet can help to increase success of intubation in operating rooms.

However, some complications from intubating stylets have been reported including mucosal bleeding, perforation of the trachea or esophagus, and sore throat. In 2018, one study has assessed the effect of adding a stylet in case of difficult intubation in prehospital setting.However, in ICU, the systematic use of a stylet is still debated and recent recommendations do not recommend to use or not to use such devices for first-pass intubation. The device chosen for intubation may therefore be a confounding factor between the relation of stylet use and first-attempt success.The routine use of a stylet for first-pass intubation using laryngoscopes in ICU has never been assessed and benefit remains to be established.

The investigators hypothesis that adding stylet to endotracheal tube will increase the frequency of successful first-pass intubation compared with use endotracheal tube alone (i.e, without stylet) in ICU patients needing mechanical ventilation.

Study Type

Interventional

Enrollment (Actual)

1040

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Languedoc-Roussillon
      • Montpellier, Languedoc-Roussillon, France, 34295
        • Centre Hospitalier Universitaire Montpellier, Saint Eloi

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • Patients must be present in the intensive care unit (ICU) and require mechanical ventilation through an orotracheal tube.
  • Adult (age ≥ 18 years)
  • Subjects must be covered by public health insurance
  • Written informed consent from the patient or proxy (if present) before inclusion or once possible when patient has been included in a context of emergency.

Exclusion Criteria:

  • Refusal of study participation or to pursue the study by the patient
  • Pregnancy or breastfeeding
  • Absence of coverage by the French statutory healthcare insurance system
  • protected person
  • intubation in case of cardio circulatory arrest
  • Previous intubation during the same ICU stay and already included in the study

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: ENDOTRACHEAL TUBE + STYLET
The experimental group consists in intubating the trachea with an endotracheal tube + stylet with a "straight-to-cuff" shape and a bend angle of 25° to 35°.
The experimental group consists in intubating the trachea with an endotracheal tube + stylet with a "straight-to-cuff" shape and a bend angle of 25° to 35°
Active Comparator: ENDOTRACHEAL TUBE ALONE
The control group consists in intubating the trachea with an endotracheal tube alone (i.e, without stylet).
intubating the trachea with an endotracheal tube alone

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Number of patients with successful first-pass orotracheal intubation
Time Frame: At intubation
the proportion of patients with successful first-pass orotracheal intubation
At intubation

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Complications related to intubation
Time Frame: 1 hour after intubation
severe hypoxemia defined by lowest oxygen saturation (SpO2) < 80 %, severe cardiovascular collapse, defined as systolic blood pressure less than 65 mm Hg recorded at least once or less than 90 mm Hg lasting 30 minutes despite 500-1,000 ml of fluid loading (crystalloids solutions) or requiring introduction or increasing doses by more than 30% of vasoactive support, cardiac arrest, death during intubation; moderate: difficult intubation, severe ventricular or supraventricular arrhythmia requiring intervention, oesophageal intubation, agitation, pulmonary aspiration, dental injuries
1 hour after intubation

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Lowest SpO2 up to 24 hours after intubation
Time Frame: up to 24 hours after intubation
Assessment of the value of the lowest SpO2
up to 24 hours after intubation
Highest positive end expiratory pressure (PEEP) up to 24 hours after intubation
Time Frame: up to 24 hours after intubation
Assessment of the value of the highest PEEP
up to 24 hours after intubation
Highest fraction of inspired oxygen (FiO2) up to 24 hours after intubation
Time Frame: up to 24 hours after intubation
Assessment of the value of the highest FiO2
up to 24 hours after intubation
lowest SpO2 < 90%
Time Frame: during intubation
incidence of lowest SpO2 less than 90% from induction to 2 minutes after intubation
during intubation
Change in SpO2
Time Frame: during intubation
Change in SpO2 from SpO2 at induction to lowest SpO2
during intubation
desaturation
Time Frame: during intubation
desaturation, defined as a change in SpO2 of more than 3% from induction to 2 minutes after intubation
during intubation
Cormack Lehane
Time Frame: during intubation
Cormack-Lehane grade of glottic view
during intubation
difficulty of intubation
Time Frame: during intubation
operator-assessed difficulty of intubation
during intubation
additional airway equipment or second operator
Time Frame: during intubation
need for additional airway equipment or a second operator
during intubation
laryngoscopy attempts
Time Frame: during intubation
number of laryngoscopy attempts
during intubation
Lowest SpO2 from 0-1 hour post intubation
Time Frame: up to 1 hour after intubation
Assessment of the value of the lowest SpO2 from 0-1 hours after intubation
up to 1 hour after intubation
Highest FiO2 from 0-1 hour post intubation
Time Frame: up to 1 hour after intubation
Assessment of the value of the highest FiO2 from 0-1 hours after intubation
up to 1 hour after intubation
Highest PEEP from 0-1 hour post intubation
Time Frame: up to 1 hour after intubation
Assessment of the value of the highest PEEP from 0-1 hours after intubation
up to 1 hour after intubation
Lowest SpO2 from 1-6 hours post intubation
Time Frame: From 1 to 6 hours after intubation
Assessment of the value of the lowest SpO2 from 1-6 hours after intubation
From 1 to 6 hours after intubation
Highest FiO2 from 1-6 hours post intubation
Time Frame: From 1 to 6 hours after intubation
Assessment of the value of the highest FiO2 from 1-6 hours after intubation
From 1 to 6 hours after intubation
Highest PEEP from 1-6 hours post intubation
Time Frame: From 1 to 6 hours after intubation
Assessment of the value of the highest PEEP from 1-6 hours after intubation
From 1 to 6 hours after intubation
new infiltrate
Time Frame: Up to 48 hours after intubation
new infiltrate on chest imaging in the 48 hours after intubation
Up to 48 hours after intubation
new pneumothorax
Time Frame: Up to 24 hours after intubation
new pneumothorax on chest imaging in the 24 hours after intubation
Up to 24 hours after intubation
new pneumomediastinum
Time Frame: Up to 24 hours after intubation
new pneumomediastinum on chest imaging in the 24 hours after intubation
Up to 24 hours after intubation
Intensive care unit (ICU) length of stay
Time Frame: Up to 90 days after intubation
ICU length of stay
Up to 90 days after intubation
ICU-free days
Time Frame: Up to 90 days after intubation
ICU-free days
Up to 90 days after intubation
invasive ventilator-free days
Time Frame: Up to 90 days after intubation
invasive ventilator-free days
Up to 90 days after intubation
mortality rate on day 28
Time Frame: Up to 28 days after intubation
mortality rate on day 28
Up to 28 days after intubation
In hospital mortality
Time Frame: Up to 90 days after intubation
in hospital mortality
Up to 90 days after intubation
mortality rate on day 90
Time Frame: Up to 90 days after intubation
mortality rate on day 90
Up to 90 days after intubation

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

October 1, 2019

Primary Completion (Actual)

March 17, 2020

Study Completion (Actual)

June 15, 2020

Study Registration Dates

First Submitted

August 29, 2019

First Submitted That Met QC Criteria

September 3, 2019

First Posted (Actual)

September 6, 2019

Study Record Updates

Last Update Posted (Estimated)

September 30, 2025

Last Update Submitted That Met QC Criteria

September 26, 2025

Last Verified

September 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • RECHMPL19_0216

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Sharing Time Frame

12 months after the main publication

IPD Sharing Access Criteria

Data are provided to qualified investigators free of charge. Required documents to request data include a summary of the research plan, request form, and institutional review board (IRB) review. Dataset will be shared after careful examination by the study board of investigators.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Critically Ill

Clinical Trials on ENDOTRACHEAL TUBE + STYLET

Subscribe